These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer. Linder S, Söderlund C. Hepatogastroenterology; 2001 Dec 01; 48(38):387-92. PubMed ID: 11379315 [Abstract] [Full Text] [Related]
28. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Bergquist A, Glaumann H, Persson B, Broomé U. Hepatology; 1998 Feb 01; 27(2):311-6. PubMed ID: 9462625 [Abstract] [Full Text] [Related]
29. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis. Cholongitas E, Papatheodoridis GV, Zappoli P, Giannakopoulos A, Patch D, Marelli L, Shusang V, Kalambokis G, Shirling G, Rolando N, Burroughs AK. Liver Transpl; 2007 Apr 01; 13(4):552-7. PubMed ID: 17394153 [Abstract] [Full Text] [Related]
39. Colorectal cancer after orthotopic liver transplantation. Silva MA, Jambulingam PS, Mirza DF. Crit Rev Oncol Hematol; 2005 Oct 01; 56(1):147-53. PubMed ID: 16140543 [Abstract] [Full Text] [Related]
40. Risk of colon cancer in patients with ulcerative colitis is potentiated by the presence of primary sclerosing cholangitis. Kingham JG. Hepatology; 1997 Jan 01; 25(1):254. PubMed ID: 8985303 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]